Señales en vivo de 237690.KQ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 02:30):

Stats
Volumen de hoy	73 713.00
Volumen promedio	243 139
Capitalización de mercado	1 622.64B
EPS	KRW0 ( 2024-02-13 )
Próxima fecha de ganancias	( KRW355.90 ) 2024-04-30
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW167.57 (0.20%)

Volumen Correlación

Largo: -0.26 (neutral)

Corto: 0.39 (neutral)

Signal:(55.45) Neutral

ST Pharm Co.,Ltd. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ST Pharm Co.,Ltd. Correlación - Moneda/Commodity

-0.28
( neutral )

0.01
( neutral )

0.59
( weak )

-0.10
( neutral )

0.06
( neutral )

0.49
( neutral )

ST Pharm Co.,Ltd. Finanzas

Annual	2023
Ingresos:	KRW284.99B
Beneficio Bruto:	KRW106.63B (37.41 %)
EPS:	KRW1 041.07

FY	2023
Ingresos:	KRW284.99B
Beneficio Bruto:	KRW106.63B (37.41 %)
EPS:	KRW1 041.07

FY	2022
Ingresos:	KRW249.32B
Beneficio Bruto:	KRW83.28B (33.40 %)
EPS:	KRW957.00

Financial Reports:

No articles found.

ST Pharm Co.,Ltd.

ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.

Actualizaciones en tiempo real para ST Pharm Co.,Ltd. [237690.KQ]

Upcoming Earnings Alert